About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 693643, 13 pages
http://dx.doi.org/10.1155/2013/693643
Review Article

HLA-G/C, miRNAs, and Their Role in HIV Infection and Replication

1Institute for Maternal and Child Health, IRCCS Burlo Garofolo, 34137 Trieste, Italy
2University of Trieste, 34128 Trieste, Italy

Received 21 March 2013; Revised 3 May 2013; Accepted 7 May 2013

Academic Editor: Enrique Medina-Acosta

Copyright © 2013 Fulvio Celsi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Apps, Y. Qi, J. M. Carlson, et al., “Influence of HLA-C expression level on HIV control,” Science, vol. 340, no. 6128, pp. 87–91, 2013.
  2. S. Buranapraditkun, U. Hempel, P. Pitakpolrat et al., “A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected thais,” PLoS ONE, vol. 6, no. 8, Article ID e23603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Fellay, K. V. Shianna, D. Ge et al., “A whole-genome association study of major determinants for host control of HIV-1,” Science, vol. 317, no. 5840, pp. 944–947, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Trachtenberg, T. Bhattacharya, M. Ladner, J. Phair, H. Erlich, and S. Wolinsky, “The HLA-B/-C haplotype block contains major determinants for host control of HIV,” Genes and Immunity, vol. 10, no. 8, pp. 673–677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Segat, E. Catamo, A. Fabris et al., “HLA-G*0105N allele is associated with augmented risk for HIV infection in white female patients,” AIDS, vol. 24, no. 12, pp. 1961–1964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Larsen, R. Zinyama, P. Kallestrup, et al., “HLA-G 3′ untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected zimbabwean population,” The Journal of Infectious Diseases, vol. 207, no. 6, pp. 903–906, 2013.
  7. B. R. Cullen, “HIV-1 auxiliary proteins: making connections in a dying cell,” Cell, vol. 93, no. 5, pp. 685–692, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. A. D. Frankel and J. A. T. Young, “HIV-1: fifteen proteins and an RNA,” Annual Review of Biochemistry, vol. 67, pp. 1–25, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. R. Littman, “Chemokine receptors: keys to AIDS pathogenesis?” Cell, vol. 93, no. 5, pp. 677–680, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Karn and C. M. Stoltzfus, “Transcriptional and posttranscriptional regulation of HIV-1 gene expression,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 2, 2012.
  11. M. W. Wright and E. A. Bruford, “Naming “junk”: human non-protein coding RNA (ncRNA) gene nomenclature,” Human Genomics, vol. 5, no. 2, pp. 90–98, 2011. View at Scopus
  12. P. P. Amaral, M. B. Clark, D. K. Gascoigne, M. E. Dinger, and J. S. Mattick, “LncRNAdb: a reference database for long noncoding RNAs,” Nucleic Acids Research, vol. 39, no. 1, pp. D146–D151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Thomson and H. Lin, “The biogenesis and function of PIWI proteins and piRNAs: progress and prospect,” Annual Review of Cell and Developmental Biology, vol. 25, pp. 355–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. S. Mattick and I. V. Makunin, “Small regulatory RNAs in mammals,” Human Molecular Genetics, vol. 14, no. 1, pp. R121–R132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. J. Adams and P. Parham, “Species-specific evolution of MHC class I genes in the higher primates,” Immunological Reviews, vol. 183, pp. 41–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T. A. M. Groothuis, A. C. Griekspoor, J. J. Neijssen, C. A. Herberts, and J. J. Neefjes, “MHC class I alleles and their exploration of the antigen-processing machinery,” Immunological Reviews, vol. 207, pp. 60–76, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Paul, F. Adrian Cabestre, E. C. Ibrahim et al., “Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells,” Human Immunology, vol. 61, no. 11, pp. 1138–1149, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. N. Antoniou, S. J. Powis, and T. Elliott, “Assembly and export of MHC class I peptide ligands,” Current Opinion in Immunology, vol. 15, no. 1, pp. 75–81, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. V. S. Hill, “Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome,” Parasitology, vol. 112, supplement, pp. S75–S84, 1996. View at Scopus
  20. A. Neisig, C. J. M. Melief, and J. Neefjes, “Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction,” Journal of Immunology, vol. 160, no. 1, pp. 171–179, 1998. View at Scopus
  21. C. S. Falk and D. J. Schendel, “HLA-C revisited. Ten years of change,” Immunologic Research, vol. 16, no. 2, pp. 203–214, 1997. View at Scopus
  22. M. Colonna, G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger, “HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 12000–12004, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. S. I. Khakoo, C. L. Thio, M. P. Martin et al., “HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection,” Science, vol. 305, no. 5685, pp. 872–874, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. T. Tiemessen, M. Paximadis, G. Minevich et al., “Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype,” Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 3, pp. 181–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. K. L. Collins, B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore, “HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes,” Nature, vol. 391, no. 6665, pp. 397–401, 1998. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Alcami and U. H. Koszinowski, “Viral mechanisms of immune evasion,” Trends in Microbiology, vol. 8, no. 9, pp. 410–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Thomas, R. Apps, Y. Qi et al., “HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C,” Nature Genetics, vol. 41, no. 12, pp. 1290–1294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Moreau, F. Adrian-Cabestre, C. Menier et al., “IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes,” International Immunology, vol. 11, no. 5, pp. 803–811, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Cirulli, J. Zalatan, M. McMaster et al., “The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G,” Diabetes, vol. 55, no. 5, pp. 1214–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. W.-H. Yan, “HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy,” Endocrine, Metabolic and Immune Disorders, vol. 11, no. 1, pp. 76–89, 2011. View at Scopus
  31. E. D. Carosella, P. Paul, P. Moreau, and N. Rouas-Freiss, “HLA-G and HLA-E: fundamental and pathophysiological aspects,” Immunology Today, vol. 21, no. 11, pp. 532–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Rouas-Freiss, R. E. Marchal, M. Kirszenbaum, J. Dausset, and E. D. Carosella, “The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 10, pp. 5249–5254, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Lozano, R. González, J. M. Kindelán et al., “Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule,” AIDS, vol. 16, no. 3, pp. 347–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Onno, C. Pangault, G. Le Friec, V. Guilloux, P. André, and R. Fauchetz, “Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection,” Journal of Immunology, vol. 164, no. 12, pp. 6426–6434, 2000. View at Scopus
  35. V. Piguet, L. Wan, C. Borel et al., “HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes,” Nature Cell Biology, vol. 2, no. 3, pp. 163–167, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Williams, J. F. Roeth, M. R. Kasper, R. I. Fleis, C. G. Przybycin, and K. L. Collins, “Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking,” Journal of Virology, vol. 76, no. 23, pp. 12173–12184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. O. Schwartz, V. Maréchal, S. Le Gall, F. Lemonnier, and J.-M. Heard, “Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein,” Nature Medicine, vol. 2, no. 3, pp. 338–342, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. S. L. Gall, F. Buseyne, A. Trocha, B. D. Walker, J.-M. Heard, and O. Schwartz, “Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation,” Journal of Virology, vol. 74, no. 19, pp. 9256–9266, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. E. Greenberg, A. J. Lafrate, and J. Skowronski, “The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes,” The EMBO Journal, vol. 17, no. 10, pp. 2777–2789, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. M. R. Kasper and K. L. Collins, “Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells,” Journal of Virology, vol. 77, no. 5, pp. 3041–3049, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. G. B. Cohen, R. T. Gandhi, D. M. Davis et al., “The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells,” Immunity, vol. 10, no. 6, pp. 661–671, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Pizzato, M. Derrien, and F. Lenfant, “The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation,” Human Immunology, vol. 65, no. 11, pp. 1389–1396, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Nattermann, H. D. Nischalke, V. Hofmeister et al., “HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells,” Antiviral Therapy, vol. 10, no. 1, pp. 95–107, 2005. View at Scopus
  44. M. Barcova, L. Kacani, C. Speth, and M. P. Dierich, “gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-γ production,” Journal of Infectious Diseases, vol. 177, no. 4, pp. 905–913, 1998. View at Scopus
  45. C. Matte, J. Lajoie, J. Lacaille, L. S. Zijenah, B. J. Ward, and M. Roger, “Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women,” AIDS, vol. 18, no. 3, pp. 427–431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Derrien, N. Pizzato, G. Dolcini et al., “Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1,” The Journal of General Virology, vol. 85, no. 7, pp. 1945–1954, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Lenfant, N. Pizzato, S. Liang, C. Davrinche, P. Le Bouteiller, and A. Horuzsko, “Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice,” The Journal of General Virology, vol. 84, no. 2, pp. 307–317, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. Lozano, R. González, J. M. Kindelán et al., “Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule,” AIDS, vol. 16, no. 3, pp. 347–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Donaghy, F. Gros, L. Amiot et al., “Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 236–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Murdaca, P. Contini, M. Setti et al., “Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution,” Clinical Immunology, vol. 133, no. 2, pp. 238–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Rebmann, A. Busemann, M. Lindemann, and H. Grosse-Wilde, “Detection of HLA-G5 secreting cells,” Human Immunology, vol. 64, no. 11, pp. 1017–1024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Lajoie, J. Fontaine, C. Tremblay, J.-P. Routy, J. Poudrier, and M. Roger, “Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection,” AIDS, vol. 23, no. 11, pp. 1437–1440, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. M. D. Hazenberg, S. A. Otto, B. H. B. Van Benthem et al., “Persistent immune activation in HIV-1 infection is associated with progression to AIDS,” AIDS, vol. 17, no. 13, pp. 1881–1888, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. W. J. R. Turk, J. Kimani, T. Bielawny, et al., “Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort,” AIDS, vol. 27, no. 1, pp. 7–15, 2013.
  55. M. Le Discorde, C. Le Danff, P. Moreau, N. Rouas-Freiss, and E. D. Carosella, “HLA-G*0105N null allele encodes functional HLA-G isoforms,” Biology of Reproduction, vol. 73, no. 2, pp. 280–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. M. J. Castro, P. Morales, J. Martinez-Laso et al., “Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae,” Human Immunology, vol. 61, no. 11, pp. 1164–1168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. E. C. Castelli, P. Moreau, A. O. E. Chiromatzo et al., “In silico analysis of microRNAS targeting the HLA-G 3′ untranslated region alleles and haplotypes,” Human Immunology, vol. 70, no. 12, pp. 1020–1025, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. X.-M. Zhu, T. Han, X.-H. Wang et al., “Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells,” American Journal of Obstetrics and Gynecology, vol. 202, no. 6, pp. 592.e1–592.e7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. I. Manaster, D. Goldman-Wohl, C. Greenfield et al., “MiRNA-mediated control of HLA-G expression and function,” PLoS ONE, vol. 7, no. 3, Article ID e33395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Snary, C. J. Barnstable, W. F. Bodmer, and M. J. Crumpton, “Molecular structure of human histocompatibility antigens: the HLA-C series,” European Journal of Immunology, vol. 7, no. 8, pp. 580–585, 1977. View at Scopus
  61. S. Kulkarni, R. Savan, Y. Qi et al., “Differential microRNA regulation of HLA-C expression and its association with HIV control,” Nature, vol. 472, no. 7344, pp. 495–498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. J. J. Neefjes and H. L. Ploegh, “Allele and locus-specific differences in cell surface expression and the association of HLA class I heavb chain with β2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association,” European Journal of Immunology, vol. 18, no. 5, pp. 801–810, 1988. View at Scopus
  63. A. Specht, A. Telenti, R. Martinez et al., “Counteraction of HLA-C-mediated immune control of HIV-1 by Nef,” Journal of Virology, vol. 84, no. 14, pp. 7300–7311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Fellay, D. Ge, K. V. Shianna et al., “Common genetic variation and the control of HIV-1 in humans,” PLoS Genetics, vol. 5, no. 12, Article ID 1000791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. T. W. Corrah, N. Goonetilleke, J. Kopycinski et al., “Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression,” Journal of Virology, vol. 85, no. 7, pp. 3367–3374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Gatignol, S. Laine, and G. Clerzius, “Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?” Retrovirology, vol. 2, article 65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Qian, X. Zhong, L. Yu, B. Ding, P. De Haan, and K. Boris-Lawrie, “HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 2, pp. 605–610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Bivalkar-Mehla, J. Vakharia, R. Mehla et al., “Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system,” Virus Research, vol. 155, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. A. M. Hayes, S. Qian, L. Yu, and K. Boris-Lawrie, “Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1,” Retrovirology, vol. 8, no. 1, article 36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. G. Sun, H. Li, X. Wu et al., “Interplay between HIV-1 infection and host microRNAs,” Nucleic Acids Research, vol. 40, no. 5, pp. 2181–2196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. D. C. Krakauer and M. Nowak, “T cell induced pathogenesis in HIV: bystander effects and latent infection,” Proceedings of the Royal Society B, vol. 266, no. 1423, pp. 1069–1075, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. L. Houzet, M. L. Yeung, V. de Lame, D. Desai, S. M. Smith, and K.-T. Jeang, “MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals,” Retrovirology, vol. 5, no. 1, article 118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. K. W. Witwer, A. K. Watson, J. N. Blankson, and J. E. Clements, “Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients,” Retrovirology, vol. 9, no. 1, article 5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Huang, F. Wang, E. Argyris et al., “Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes,” Nature Medicine, vol. 13, no. 10, pp. 1241–1247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. J. K. Ahluwalia, S. Z. Khan, K. Soni et al., “Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication,” Retrovirology, vol. 5, article 117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. K. Chiang and A. P. Rice, “MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes,” Viruses, vol. 4, no. 9, pp. 1390–1409, 2012.
  77. K. Chiang, H. Liu, and A. P. Rice, “miR-132 enhances HIV-1 replication,” Virology, vol. 438, no. 1, pp. 1–4, 2013. View at Publisher · View at Google Scholar
  78. S. T. Chang, M. J. Thomas, P. Sova, R. R. Green, R. E. Palermo, and M. G. Katze, “Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microRNA expression patterns and candidate novel microRNAs differentially expressed upon infection,” MBio, vol. 4, no. 1, 2013. View at Publisher · View at Google Scholar
  79. T.-L. Sung and A. P. Rice, “miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1,” PLoS Pathogens, vol. 5, no. 1, Article ID e1000263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. J. M. Sisk, J. E. Clements, and K. W. Witwer, “miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction,” Viruses, vol. 4, no. 12, pp. 1844–1864, 2012.
  81. X. Wang, L. Ye, W. Hou et al., “Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection,” Blood, vol. 113, no. 3, pp. 671–674, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. S. Swaminathan, J. Zaunders, J. Wilkinson, K. Suzuki, and A. D. Kelleher, “Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?” Blood, vol. 113, no. 20, pp. 5029–5030, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. Y. Bennasser, S.-Y. Le, M. L. Yeung, and K.-T. Jeang, “HIV-1 encoded candidate micro-RNAs and their cellular targets,” Retrovirology, vol. 1, article 43, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Bennasser, S.-Y. Le, M. Benkirane, and K.-T. Jeang, “Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing,” Immunity, vol. 22, no. 5, pp. 607–619, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Omoto, M. Ito, Y. Tsutsumi et al., “HIV-1 nef suppression by virally encoded microRNA,” Retrovirology, vol. 1, article 44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Omoto and Y. R. Fujii, “Regulation of human immunodeficiency virus 1 transcription by nef microRNA,” Journal of General Virology, vol. 86, no. 3, pp. 751–755, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. Z. Klase, R. Winograd, J. Davis et al., “HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression,” Retrovirology, vol. 6, article 18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Lin and B. R. Cullen, “Analysis of the interaction of primate retroviruses with the human RNA interference machinery,” Journal of Virology, vol. 81, no. 22, pp. 12218–12226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. M. L. Yeung, Y. Bennasser, K. Watashi, S.-Y. Le, L. Houzet, and K.-T. Jeang, “Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid,” Nucleic Acids Research, vol. 37, no. 19, pp. 6575–6586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. A. W. Whisnant, H. P. Bogerd, O. Flores, et al., “In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms,” MBio, vol. 4, no. 2, 2013.
  91. N. Alkhouly, I. Shehata, M. B. Ahmed, H. Shehata, S. Hassan, and T. Ibrahim, “HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker,” Medical Oncology, vol. 30, no. 1, 2013.